BioCentury
ARTICLE | Company News

Novartis, Tribute Pharmaceuticals deal

November 10, 2014 8:00 AM UTC

Novartis sold to Tribute Canadian rights to Fiorinal butalbital/acetylsalicylic acid/caffeine anhydrous, Fiorinal C butalbital/acetylsalicylic acid/caffeine anhydrous/codeine phosphate, Visken pindolo...